Raymond James & Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-42,000
Closed -$1K 3931
2022
Q3
$1K Hold
42,000
﹤0.01% 3924
2022
Q2
$7K Sell
42,000
-56,000
-57% -$783K ﹤0.01% 3954
2022
Q1
$254K Buy
98,000
+40,000
+69% +$978K ﹤0.01% 3522
2021
Q4
$441K Hold
58,000
﹤0.01% 3179
2021
Q3
$470K Hold
58,000
﹤0.01% 3111
2021
Q2
$563K Sell
58,000
-2,000
-3% -$60.6K ﹤0.01% 2998
2021
Q1
$729K Sell
60,000
-79,600
-57% -$2.33M ﹤0.01% 2724
2020
Q4
$339K Buy
+139,600
New +$2.6M ﹤0.01% 3054
2020
Q1
Sell
-10,600
Closed -$23K 3514
2019
Q4
$23K Buy
+10,600
New +$276K ﹤0.01% 3606
2019
Q1
Sell
-14,000
Closed -$50K 3623
2018
Q4
$50K Sell
14,000
-14,000
-50% -$333K ﹤0.01% 3384
2018
Q3
$171K Buy
28,000
+13,000
+87% +$298K ﹤0.01% 3341
2018
Q2
$135K Sell
15,000
-18,000
-55% -$372K ﹤0.01% 3351
2018
Q1
$61K Buy
33,000
+3,000
+10% +$55.8K ﹤0.01% 3305
2017
Q4
$131K Sell
30,000
-300
-1% -$4.76K ﹤0.01% 3161
2017
Q3
$69K Buy
+30,300
New +$458K ﹤0.01% 3217
2017
Q2
Sell
-21,000
Closed -$1K 3344
2017
Q1
$1K Sell
21,000
-18,500
-47% -$254K ﹤0.01% 3283
2016
Q4
$5K Sell
39,500
-57,000
-59% -$1.05M ﹤0.01% 3209
2016
Q3
$170K Sell
96,500
-43,000
-31% -$1.11M ﹤0.01% 2895
2016
Q2
$100K Buy
+139,500
New +$3.95M ﹤0.01% 2804

Other funds holding BHC

Raymond James & Associates's BHC Position: Q3 2024 in Review

Raymond James & Associates reduced its Bausch Health (BHC) stake by 23% in Q3 2024, selling an estimated $42.2K and leaving 21,253 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Raymond James & Associates first reported a position in BHC in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.95M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Raymond James & Associates held 21,253 shares of Bausch Health worth $173K as of Q3 2024.
  • Raymond James & Associates sold 6,399 Bausch Health shares in Q3 2024, an estimated $42.2K.
  • Bausch Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3683 holding.
  • Raymond James & Associates first reported a position in Bausch Health in Q3 2013 and has held it in 45 quarters since.
  • Raymond James & Associates's Bausch Health position peaked at $5.95M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.